Scinai Immunotherapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $168 | $284 | $0 | $0 |
Gross Profit | -249 | -164 | -157 | -84 |
EBITDA | -1,922 | -1,531 | -1,772 | -1,739 |
EBIT | -2,420 | -2,027 | -1,928 | -1,823 |
Net Income | 10,455 | -2,322 | -2,159 | -2,330 |
Net Change In Cash | 168 | 284 | 0 | 0 |
Free Cash Flow | -2,042 | -1,764 | -1,465 | -1,459 |
Cash | 1,032 | 3,076 | 4,826 | 4,870 |
Basic Shares | 843 | 637 | 506 | 300 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -512 | |||
EBITDA | -9,192 | -10,499 | -10,391 | 2,750 |
EBIT | -9,706 | -11,061 | -10,862 | 2,281 |
Net Income | -6,500 | -5,796 | -8,205 | -1,386 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,019 | -8,100 | -7,565 | -24,476 |
Cash | 4,870 | 14,075 | 17,374 | 2,931 |
Basic Shares | 390 | 188 | 141 | 110 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $12.43 |
2024-06-30 | -$4.30 |
2024-03-31 | -$0.47 |
2023-12-31 | -$24 |
